Background: Proteasome inhibitors have been used in cancer therapy, and the search for new compounds with higher efficacy and specificity for tumor cells is imperative. Results: Fenbendazole shows a strong antiproliferative property preferentially against cancer cells. Conclusion: The growth-inhibitory activity of FZ can be partly attributed to interference in the proteasomal function. Significance: This new proteasome-targeting compound may be useful in cancer therapy.
V./
In recent years, there has been a great deal of interest in proteasome inhibitors as a novel class of anticancer drugs. We report that fenbendazole (FZ) (methyl AT-(6-phenylsulfanyll//-benzimidazol-2-yl)carbamate) exhibits a potent growth-in hibitory activity against cancer cell lines but not normal cells. We show here, using fluorogenic substrates, that FZ treatment leads to the inhibition of proteasomal activity in the cells. Succinyl-Leu-Leu-Val-Tyr-methylcoumarinamide (MCA), benzyloxycarbonyl-Leu-Leu-Glu-7-amido-4-MCA, and £-butoxycarbonyl-Gln-Ala-Arg-7-amido-4-MCA fluorescent derivatives were used to assess chymotrypsin-like, post-glutamyl peptidylhydrolyzing, and trypsin-like protease activities, respectively. Non-small cell lung cancer cells transiently transfected with an expression plasmid encoding pdlEGFP and treated with FZ showed an accumulation of the green fluorescent protein in the cells due to an increase in its half-life. A number of apoptosis regulatory proteins that are normally degraded by the ubiquitinproteasome pathway like cyclins, p53, and IicBa were found to be accumulated in FZ-treated cells. In addition, FZ induced dis tinct ER stress-associated genes like GRP78, GADDI53, ATF3, IREla, and NOXA in these cells. Thus, treatment of human NSCLC cells with fenbendazole induced endoplasmic reticulum stress, reactive oxygen species production, decreased mitochon drial membrane potential, and cytochrome c release that even tually led to cancer cell death. This is the first report to demon strate the inhibition of proteasome function and induction of endoplasmic reticulum stress/reactive oxygen species-depend ent apoptosis in human lung cancer cell lines by fenbendazole, which may represent a new class of anticancer agents showing selective toxicity against cancer cells.
The proteasome is the major proteolytic complex, responsi ble for the degradation of a number of cellular proteins in eukaryotes. Proteasomes are abundant in both cytoplasm and nucleus, where they catalyze the ATP-dependent proteolysis of short-lived regulatory proteins as well as misfolded, damaged, and abnormal proteins. Cancer cells accumulate more oxidized or mutated/damaged proteins that are effectively removed by the proteasomes. Consequently, they are likely to be more dependent on proteasomal activity as compared with normal cells (1, 2) . With that rationale, proteasome has been targeted for the treatment of human cancer. Bortezomib is the first pro teasome inhibitor approved by the Food and Drug Administra tion to treat patients with advanced hematologic malignancies. Unfortunately, the efficacy of the treatment has been restricted to a narrow therapeutic window. Bortezomib as a single agent has limited activity in non-small cell lung cancer, and it has been reported earlier to have no anti-tumor activity in H460 xenografts (3, 4) . Therefore, the search for new proteasomal inhibitors that can preferentially eradicate cancer cells is of high priority for effective treatment of the disease.
Fenbendazole (methyl AA(6-phenylsulfanyl-lH-benzimidazol-2-yl) carbamate) is an anthelmintic drug belonging to the benzimidazole group mainly used for the treatment of pinworm in animals (Fig. LA) . Clinically, two benzimidazole derivatives, mebendazole (methyl 5-benzoyl-2-benzimidazole-carbamate) and albendazole (methyl (5-propylthio)-l/f-benzimidazol-2-yl carbamate methylester) have been used to treat human alveolar echinococcosis, a lethal pulmonary helminthic infection (5) . Although echinococcosis requires long-term high dose treat ment with mebendazole, the incidence of severe side effects to the host is considerably low (6, 7) . Thus, benzimidazoles have a good track record as anthelmintic agents and have a wide mar gin of safety in humans. The selectivity of these drugs for the parasite is explained on the basis of irreversible blockade in uptake of glucose in parasite, which leads to depletion of glyco gen storage and degeneration of endoplasmic reticulum in the germinal layers, resulting in cell death (8) . In addition, a prefer ential affinity of these drugs for ^-tubulin of the parasite as compared with that of the host has also been reported (9) .
Fenbendozole, Antiproliferative Proteasome-targeting Agent
Although FZ is known to inhibit polymerization and alter microtubule function in parasitic cells, its effect on mammalian tubulin has not been looked into (10) (11) (12) . Another compound of this class, mebendazole, has been earlier reported to have a mild tubulin depolymerizing activity in human cancer cells. The structural explanation for this preferential binding for par asite tubulin has been provided on the basis of difference in certain key residues between mammals and parasites leading to "closing off' of the hydrophobic pocket into which the benz imidazoles bind, thus making it inaccessible (13) . In the past, there have been a few reports regarding the use of anthelmintic benzimidazoles in human cancer (14) (15) (16) (17) (18) , but the molecular mechanism of their inhibitory action remains elusive.
In the present study, we report that treatment of human lung cancer cell lines with fenbendazole (FZ)3 induces apoptotic cell death, whereas primary normal cells in culture remain widely unaffected. FZ exerts its cytotoxicity possibly through interfer ence with proteasome function and induction of unfolded pro tein response, ultimately resulting in cancer cell death via the intrinsic pathway of apoptosis. FZ; 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT); colchicine; MG132; cycloheximide; JC-1 (5,5' ,6,6' -tetrachloro-1,1' ,3,3' -tetraethyl-benzimidazoleocarbocyanine iodide); Hoechst 33342; propidium iodide; Ar-acetylcysteine; TNFa; Z-VAD-FMK; proteasomal and caspase sub strates; Tiron; anti-jS-actin; anti-ubiquitin; anti-GFP; antip27I<ipl; anti-Bcl2; anti-mouse IgG-fluorescein isothiocyanate (FITC); horseradish peroxidase (HRP)-conjugated anti-mouse, anti-rabbit, and anti-goat IgGs; and all of the cell culture reagents were purchased from Sigma. IKK inhibitor wedelolaetone was obtained from Calbiochem. Anti-p53 (Bp53-12 and DOl), anti-p21, anti MDM-2, anti-cyclin Bl, anti-Bax, anti cytochrome c, anti-I/<Ba, and anti-phospho-JNK were pur chased from Santa Cruz Biotechnology, Inc. (Santa Cruz, CA).
EXPERIMENTAL PROCEDURES

Cell Culture and Chemicals-All
Cell Viability Assays-Cells (5 X 103 cells/well) were seeded into 96-well plates, and 24 h after seeding, ceils were treated with different doses of fenbendazole. Cell viability was mea sured by an MTT assay. For the cell count assay, cells were seeded at a density of 1 X 104 cells/well in 24-well culture plates and then treated with FZ. Cells were harvested at the indicated 
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time points, and viable cells were counted by the trypan blue exclusion method. All experiments were done in triplicate.
Hoechst/Propidium Iodide (PI) Staining-Following FZ treatment, Hoechst 33342 and PI were added into the medium at 100 ng/ml concentration for 15 min, and cells were then washed with prewarmed PBS and examined under a fluores cence microscope for detection of apoptotic cells.
FACS Analysis-After treatment with FZ for the indicated time intervals, cells were harvested, washed with PBS, and fixed in 70% ethanol overnight at 4 °C. The next day, cells were cen trifuged at 1000 rpm for 5 min, the supernatant was carefully aspirated, and the pellet was resuspended in PBS containing 40 /xg/ml PI and 100 /xg/ml RNase A (19) . FACS analysis was done on a BD FACSArray system, and the data were analyzed using Flowjo software.
TdT Assay-H460 cells were plated onto coverslips in 35-mm tissue culture plates at subconfluent density. 24 h after seeding, cells were either left untreated or exposed to 1 /xm FZ or 130 nmol of colchicine for 24 h. An in situ tailing reaction was performed as described by Gold et al (20) . Briefly, follow ing treatment, cells were washed with PBS and fixed in 1:3 acetomethanol. After fixation, the cells were rinsed with PBS and incubated with 0.25 units/ml A exonuclease enzyme in a moist chamber at 37 °C for 10 min. Cells were again washed with PBS and incubated with 20 units/ml TdT enzyme in the presence of 5 jtxl of 50 nmol biotin-dUTP in a humid chamber for 1 h at 37 °C. Endogenous peroxidase activity was then blocked by incubation in 3% hydrogen peroxide in methanol for 15 min at room temperature. Detection was finally done using avidin-biotin complex from an ABC kit (Vector) and 3,3 '-diaminobenzidine tetrahydrochloride substrate (Sigma).
DNA Fragmentation Assay-The DNA fragmentation assay was performed as described previously (17) . Control and FZtreated cells were washed with cold PBS. The cell pellets were lysed in lysis buffer (10 m,M Tris (pH 7,4), 10 mM EDTA (pH 8.0), and 0.5% Triton X-100) and incubated for 10 min at 4 °C and then incubated with 200 /rg/ml RNase A for 1 h at 37 °C. After centrifugation, the supernatants were incubated with 200 /xg/ml proteinase I< for 30 min at 50 °C. Next, DNA fragments were precipitated with 0.5 m NaCl and 50% isopropyl alcohol, and the samples were loaded in 2% agarose TBE gel and stained with ethidium bromide.
Immunofluorescence-Cells were grown on coverslips and treated with 1 /xm FZ or 130 nmol of colchicine for 24 h. Fol lowing treatment, cells were washed with PBS and fixed using 4% paraformaldehyde fixative. Cells were again washed with PBS and incubated with p53 antibody overnight at 4 °C. The following day, after several washes with PBS, the cells were incubated in FITC-conjugated secondary antibody for 1 h at 37 °C. Stained cells were visualized under a fluorescence microscope.
Measurement of Mitochondrial Membrane Potential and Cytochrome c
Release-A549 cells were plated onto coverslips in 35-mm tissue culture plates at subconfluent density. 24 h later, cells were exposed to the specified doses of FZ for 24 h or 10 /xm MG 132 for 12 h, following which they were incubated with 5 /xm JC-1 dye for 30 min in the C02 incubator. After several washes with prewarmed PBS, mitochondrial membrane VOLUME 287 • NUMBER 36 • AUGUST 31, 2012 Fenbendazole, Antiproliferative Proteasome-targeting Agent potential was evaluated qualitatively under a fluorescence microscope using a 568-nm filter.
The localization of cytochrome c was examined using immunofluorescent staining. Cells grown on coverslips were treated with FZ or MG 132 as specified earlier. After treatment, cells were washed twice with PBS, fixed with 4% paraformaldehyde in PBS for 20 min, permeabilized with 0.05% Triton X-100 in PBS for 5 min, washed extensively, and then blocked with goat serum in PBS for 30 min. Primary antibody (anti-cytochrome c) incubation was carried out overnight at 4°C. After several washings with PBS, cells were incubated with FITC-conjugated secondary antibody for 2 h at 37 °C, washed several times, and visualized under a fluorescence microscope.
Assay of Proteasome and Caspase-3-like Protease ActivityAfter overnight culture, cells were treated with varying doses of FZ or 10 pu MG 132 for specified time periods. Cells were then isolated and processed for proteasome activity and caspase-3-like protease activity assays (21) . The fluorogenic substrates succinyl-Leu-Leu-Val-Tyr-MCA, Z-Leu-Leu-Glu-7-amido-4~ MCA, Boc-Gln-Ala~Arg-7-amido-4-MCA, and Ac-Asp-GluVal-Asp-MCA were used to determine chymotrypsin activity, peptidylglutamyl-peptide hydrolyzing activity, trypsin-like activity, and caspase-3-like protease activity, respectively. For the in vitro assay, control cell extracts were incubated with var ious doses of FZ for 4 h or with 5 pM FZ for different times, as indicated, and assayed for protease activity. To evaluate the direct effect of FZ on the protease activity of proteasome, pure 20S proteasome (100 ng/reaction) was used instead of ceil supernatant in the protease activity assay buffer. Protease activ ities at a particular time point (30 min) within the linear range were used to calculate the data. The fluorescence intensity was measured at 380-nm excitation and 460-nm emission using a PerkinElmer Life Sciences Victor X3 fluorescence plate reader.
RT-PCR and Quantitative PCR-Cells were treated with FZ, and total RNA was isolated using the guanidium thiocyanate method (22) . Briefly, following treatment, cells were washed with PBS and lysed and collected in 400 pi of solution D (4 m guanidium thiocyanate, 0.75 m sodium citrate, 10% ALlaurylsarcosine, and 0.1 m ]3-mercaptoethanol). This was followed by the addition of 40 pi of 2 m sodium acetate (pH 4.0), 400 pi of water-saturated phenol, and 40 pi of 49:1 chloroform/isoamylalcohol. It was then mixed and incubated for 15 min on ice and centrifuged at 9000 rpm for 10 min at 4 °C. RNA was pre cipitated with an equal volume of isopropyl alcohol, resus pended in diethylpyrocarbonate-treated water, and quantified using a spectrophotometer. Finally, RNA was reverse tran scribed using oligo(dT)18 primers, and RT-PCR analysis was performed. For quantitative PCR, the RealMasterMix SYBR ROX kit from Eppendorf was used. The reactions were set up according to the manufacturer's instructions in an Eppendorf Mastercycler Realplex real-time PCR machine.
Co-immunoprecipitation and Immunoblotting Experiments-24 h after transfection with pdlEGFP plasmid, cells were treated with different doses of FZ or 10 pM MG132 for 8 h. Cells were then washed with cold PBS and lysed on ice for 30 min with Nonidet P-40 lysis buffer (50 him Tris, pH 8.0, 150 mw NaCl, 1% Nonidet P-40, complete protease inhibitor mixture). Cell lysates were briefly vortexed and centrifuged for 10 min at 15,000 X g at 4 °C, and the supernatants (total soluble extract) were used for immunoprecipitation. Protein concentration was measured according to the method of Bradford using bovine serum albumin as a standard (23) . For each immunoprecipita tion experiment, 200 pg of protein in 0.2 ml of Nonidet P-40 lysis buffer was incubated with 5 pi (2.5 pg) of GFP antibody. After overnight incubation at 4 °C with rotation, 20 pi of pro tein A/G-agarose beads were added, and incubation was con tinued at 4 °C for 5 h. The beads were washed six times with Nonidet P-40 lysis buffer. Bound proteins were eluted from the beads with SDS (IX) sample buffer, vortexed, boiled for 5 min, and analyzed by immunoblotting. The total cell lysates or the immunoprecipitated proteins were separated through 10% SDS-polyacrylamide gel electrophoresis and transferred onto polyvinylidene difluoride (PVDF) membranes (24) . The mem branes were successively incubated in blocking buffer (5% skim milk in TBST (50 him Tris, pH 7.5, 0.15 m NaCl, 0.05% Tween-20)) with primary antibody and then with secondary antibody conjugated with horseradish peroxidase. Detection was carried out with enhanced chemiluminescence reagent from Millipore. All primary antibodies were used in 1:4000 dilutions for immunoblotting.
Histone HI Kinase Assay-Commercially purified histone HI (Sigma) was incubated with CDK2 immunoprecipitated from H460 whole-cell extracts equivalent to 100 pg of total protein in 50 pi of kinase reaction buffer (50 mw Tris, pH 7.2,10 HIM MgCl2, 1 mM DTT, 5 pCi of [y-32P]ATP) for 10 min at 25 °C. Samples were analyzed by SDS-PAGE followed by autoradiography.
Pulse-Chase Experiment for the Analysis of Protein StabilityCells were plated onto 35-mm tissue culture plates, and on the following day, they were left untreated or treated with FZ and chased in the presence of cycloheximide for the indicated times. Cells collected at each time point were then processed for immunoblotting using antibodies against p53, cyclin Bl, IkB«, or Bax. For studying GFP stabilization, HI299 cells were trans fected with pdlEGFP plasmid using Lipofectamine. On the fol lowing day, the cells were either left untreated or treated with 5 pM FZ and chased in the presence of cycloheximide for the indicated time durations. They were observed under a fluores cence microscope after the indicated time points or processed for immunoblotting using anti-GFP antibody as described above.
Electrophoretic Mobility Shift Assay (EMSA)-H460 cells were treated with different doses of FZ for 4 h, and nuclear extracts were then prepared according to Schreiber et ah (25) . Briefly, 2 X ft)6 cells were washed with cold PBS and suspended in 0.4 ml of lysis buffer (10 mM HEPES, pH 7.9,10 mM KC1, 0.1 mM EDTA, 0.1 mM EGTA, 1 mM DTT, 0.5 mM phenylmethylsulfonyl fluoride, 2.0 pgtml leupeptin, 2.0 pglml aprotinin, and 0.5 mg/ml benzamidine). The cells were allowed to swell on ice for 15 min, after which 12.5 pi of 10% Nonidet P-40 was added. The tube was then vigorously mixed on a vortex machine for 10 s, and the homogenate was centrifuged for 30 s. The nuclear pellet was resuspended in 25 pi of ice-cold nuclear extraction buffer (20 mM HEPES, pH 7.9, 0.4 m NaCl, 1 mM EDTA, 1 mM EGTA, 1 mM DTT, 1 mM phenylmethylsulfonyl fluoride, 2.0 pglml leupeptin, 2.0 pglml aprotinin, and 0.5 mg/ml benzami- Fenbendazole, Antiproliferative Proteasome-targeting Agent dine), and the tube was incubated on ice for 30 min with inter mittent mixing. It was then centrifuged for 5 min at 4 °C, and the supernatant (nuclear extract) was either used immediately or stored at -70 °C for later use. The protein content was mea sured by the method of Bradford (23) .
EMSAs were performed by incubating 6 \ug of nuclear extract, with 16 fmol of 32P-end-labeled 45-mer doublestranded NFkB oligonucleotide, 5'-TTGTTACAAGGGACT-TTCCGCTGGGGACTTTCCAGGGAGGCGTGG-3' (26), for 30 min at 37 °C. The incubation mixture consisted of 2-3 /Ag of poly(dl-dC) in binding buffer (25 him HEPES, pH 7.9,0.5 mM EDTA, 0.5 mM DTT, 1% Nonidet P-40,5% glycerol, and 50 mM NaCl). The DNA-protein complex formed was separated from free oligonucleotide on 5% native polyacrylamide gel, and then the gel was then dried. The specificity of binding was deter mined by using an excess of unlabeled oligonucleotide for competition.
Secreted Alkaline Phosphatase (SEAP) Assay for ER Stress-293T cells were seeded in a 96-well plate and were transfected the next day with pSEAP-con plasmid (Clontech), which constitutively expresses SEAP. 24 h after transfection, the cells were either left unexposed or exposed to different concentra tions of the indicated drugs in fresh media containing 1% FBS. 24 h after incubation, 10 pi of conditioned culture media was removed and assessed for SEAP activity using 4-MUP substrate according to the protocol described by the manufacturer (Clon tech, Palo Alto, CA). In brief, 10 /a1 of medium was mixed with 15 /a1 of 5 X SEAP assay buffer (0.5 m Tris, pH 9.0, and 0.5% BSA) in a total volume of 50 pi in a 96-well plate and incubated at 65 °C for 30 min to inactivate endogenous SEAP activity. The plate was chilled on ice for 2 min. Then 25 pi of 1 mM 4-methylumbelliferyl phosphate substrate was added to each well and incubated at 37 °C for 2 h. The activity of SEAP was assayed using a 96-well fluorescence plate reader (PerkinElmer Multi label reader Victor X3) with excitation set at 355 nm and emis sion at 460 nm. Three independent experiments were per formed in triplicates.
Reactive Oxygen Species (ROS) Activity-A549 cells were grown on coverslips in 35-mm culture dishes and treated with 5 /am FZ or 10 /am MG132 for 4 h. NAC (10 mM) was added 2 h before the drug. To measure the production of reactive oxygen species, after treatment, cells were washed and incubated at 37 °C with 1 /am DCF-DA for 1 h in serum-free medium without phenol red. After washing twice, samples were illuminated by a 100-watt mercury lamp and viewed with an FITC filter on a Nikon fluorescent microscope to view DCFDA fluorescence. For quantitative analysis, fluorescence intensity was measured at 530 nm after excitation at 485 nm in a Victor 3X fluorometer (PerkinElmer Life Sciences).
Reporter Assays for p53 and NFkB Gene Transcription-The effect of FZ on p53-and NF^B-dependent reporter gene tran scription was measured by a luciferase assay using pWWP-Luc (27) or NFkB-Luc construct, respectively. For p53 transcrip tional activity, H1299 cells were co-transfected with pWWPluc and either pCMV vector or pCMV-p53 (WT) in a 96-well plate. Transfections were done using Lipofectamine 2000 (Invitrogen) according to the manufacturer's protocol. 24 h post-transfection, cells were left untreated or treated with 1 /am FZ for 24 h. Similarly, for NFkB reporter assay, A549 cells were co-transfected with NFkB-Luc vector carrying NFkB binding sites and pRL-SV40. The following day, cells were treated with 5 /am FZ for 4 h, followed by 30 ng/ml TNFa for 1 h, where indicated. In both cases, the cell extracts were then prepared, and luciferase activity was monitored using a Dual Luciferase assay kit from Promega as per the manufacturer's instructions. The luciferase activity was assayed using a 96-well fluorescence plate reader (PerkinElmer Life Sciences Multilabel reader Vic tor X3). pRL-SV40 Renilla vector was used for co-transfection in all cases to normalize the data, and it was transfected at a lower concentration (5-fold lower than the reporter luciferase plasmid). The data were represented as relative luciferase activ ity (the ratio of firefly to Renilla values). The experiments were performed in triplicates.
Statistical Analysis-All results are expressed as means ± S.D. unless otherwise mentioned. Student's t test was used to calculate the significance, accepting p < 0.05 as a level of significance.
RESULTS
EZ Inhibits Growth and Induces Apoptosis in Human Non
small Cell Lung Cancer Cells-To check the effect of FZ on cell growth, NSCLC cell lines (H460 and A549) were plated onto 96-well tissue culture plates, and on the following day, the cells were exposed to different doses of FZ for 48 h. The cell viability was determined by an MTT assay. Exposure to drug decreased the viability' of cells in a dose-dependent manner (Fig. IS) . The IC50 value was calculated as -1.2 and 1.6 /am for H460 and A549 cell lines, respectively. As shown in Fig. 1C , FZ reduced the viability of these cells in a time-dependent manner. To determine the cell viability for a longer duration, cell count assays were performed on alternate days for 7 days after 1 /am FZ treatment in H460, A549, and normal human bronchial epi thelial cells (Fig. 1, D-E) . Whereas H460 and A549 cells showed reduced viability when exposed to FZ, the compound showed little effect on normal human bronchial epithelial cells. We then compared the antiproliferative ability of FZ with other established anticancer drugs. The results of a time-dependent growth assay clearly indicated FZ to be a more effective cyto toxic agent as compared with cisplatin and taxol (Fig. IF) . The growth-inhibitory action of FZ in H460 and A549 cells was also compared with the Food and Drug Administration-approved proteasomal inhibitor bortezomib, and the results showed that the activities of both of the compounds were comparable (sup plemental Fig. 1) . Interestingly, when we treated HCT116 p53 f /+ and p53~;~ cells with FZ in a dose-dependent manner, P53+/+ cells showed greater sensitivity to FZ, as revealed by a relatively higher percentage of cell death (Fig. 1G) . We also assessed the anti-proliferative effect of FZ on 25 cell lines derived from different tumor types, such as lung, prostate, breast, cervix, and colon, which are listed in the NCI-60 panel designed for drug screening. Most of these cell lines had IC50 values greater than 1 /am. However, FZ induced -50% growth inhibition at 1 /am concentration in at least seven cell lines tested (supplemental Table 1 tively unaffected by its action (supplemental Fig. 2 ). The IC50 values for FZ were found to be severalfold higher in these nor mal cells than in cancer cell lines. Together, these results show that FZ acts as an inhibitor of cell proliferation in the case of cancer cells but is relatively non-toxic to normal cells.
Incubation of NSCLC cells with FZ resulted in nuclear condensation and fragmentation characteristic of apoptotic nuclear morphology ( Fig. 2A, a and b) . Cells were doublestained with Hoechst 33342 and PI to check their nuclear mor phology and plasma membrane integrity. 48-h FZ-treated cells had a significant number of apoptotic nuclei as compared with that of control untreated cells. Many of them appeared orangered in color, characteristic of late apoptosis ( Fig. 2A, c and d) . The nuclei were further labeled with a TdT-mediated dUTP nick end labeling system to verify the apoptotic nature of cell death. A significant number of TUNEL-positive cells were observed 48 h post-FZ treatment (Fig. 2B ), which were then quantified (Fig. 2C) . DNA extracted from treated cells exhibited a distinct laddering pattern, which is a characteristic of apopto tic cell death (Fig. 2D) .
When we performed flow cytometric analysis, results showed that FZ treatment caused an accumulation of cells in G2/M phase of cell cycle followed by a significant increase in the percentage of sub-Gi apoptotic population, indicative of DNA degradation (Fig. 2E ). This could be due to FZ-induced stabili zation of G2/M checkpoint regulatory molecules that contrib ute to the enhancement of cytotoxicity. Cell cycle delay at G2/M could be due to accelerated and prolonged CDK2 phosphory lation and stabilization of cyclin Bl, p53, and p21, which have been implicated in the control of the G2/M checkpoint (28) . Phosphorylation status of CDK2 kinase governs the activity of the Cdc2-cyclin Bl complex, which is responsible for the onset of mitosis. Therefore, levels of proteins involved in the G2/M transition were further examined by Western blot analysis.
FZ Treatment Results in Stability of p53 Protein-Because our earlier results indicated a possible role of p53 in sensitizing the cells toward FZ induced apoptosis, we performed Western blotting and immunofluorescence experiments for p53 follow ing FZ treatment. Fig. 3A (i and A549 ceils were treated with FZ for 24 or 48 h, and cell lysates were made and processed for immunoblotting using p53 antibody. //, A549 cells were either left untreated or treated with 1 pM FZ for 24 h and then subjected to immunofluorescence using p53 antibody and FITC-conjugated secondary antibody, a, control; b, FZ. Hi, H460 cells were left untreated or treated with 1 pM FZ for the indicated time periods, and Western blot analysis was done using antibodies against p53 (Bp53-12) and /3-actin. B, following treatment with FZ for 24 or 48 h, total RNA was isolated, and RT-PCR (/) or real-time PCR (//) was done using p53-specific primers. C, a p53 Western blot was overexposed for the detection of high molecular weight bands representing ubiquitylated p53.D, cDNA synthesized from total RNA was used for RT-PCR using primers specific for p53 target genes. E, H1299 cells were transiently transfected with pWWP-luc and either pCMV vector or pCMV-p53 (WT) construct along with pRL-SV40 plasmids in a 96-well plate. 24 h after transfection, cells were treated with 1 pm FZ for 24 h. Cells were then processed for a dual luciferase reporter gene assay. *,p < 0.01 as compared with control vector-transfected cells. F, H460 cells were treated with FZ for 24 or 48 h, and the cell lysates were prepared and processed for immunoblotting using p21 or Mdm2 antibodies. G,/, Western blot for cyclin B1;/7, result of in vitro kinase assay for CDK2 in H460 control and treated cells. FIGURE 4. FZ inhibits proteasome activity. A, H460 and A549 cells were exposed to different doses of FZ for 8 h. Cells were then collected and processed for the proteasome activity assay (chymotrypsin like protease activity) using fluorogenic substrate Z-Leu-Leu-Glu-7-amido-4-MCA as described under "Experi mental Procedures." B, H460 and A549 cells were treated with 5 /xm FZ for different time periods as indicated and processed for the proteasome assay. In A and B, the treatment groups show significant inhibition of proteasome activity as compared with control. C, H460 cells were exposed to different doses of FZ for 4 h. Cells were then collected, and cell extracts were processed for proteasome activity assays for post-glutamyl peptidyl hydrolyzing and trypsin-like protease activities using the fluorogenic substrates Z-Leu-Leu-Glu-7-amido-4-MCA and Boc-Gin-AIa-Arg-7-amido-4-MCA, respectively. D, purified 20S proteasome was incubated with different doses of FZ in the presence of chymotrypsin-like, post-glutamyl peptidyl-hydrolyzing, and trypsin-like fluorogenic substrates of proteasome, and the activities were assayed as described. MG132 was used as a positive control. *, p < 0.01 as compared with control untreated cells. Error bars, S.D. Fig. 3B (/) ), which was confirmed by real-time PCR (Fig. 3B («) ). Because p53 was not found to be up-regulated by FZ at the transcriptional level, these results prompted us to investigate further the events lead ing to its accumulation in the cell. We speculated that this could be due to inhibition of the degradation pathway, and blockage of the proteasome-mediated proteolysis step could be the cause of this stability. With this rationale, the above experiment was repeated, and interestingly, upon longer exposure of a Western blot done using p53 antibody, we could clearly detect a consid erable increase in the ubiquitylated form of wild type (WT) p53 after FZ treatment, as revealed by higher molecular weight bands corresponding to the ubiquitylated form of the protein (Fig. 3C) .
p53 protein in FZ-treated cells was not accompanied by a cor responding increase in the level of its mRNA (
FZ-induced p53Is Transcriptionally Active and Results in the Up-regulation of Its Target Genes-p53 target gene expressions were further analyzed by RT-PCR after FZ treatment. Fig. 3D shows an induction in mRNA levels of common p53 target genes likep21,BAX,MDM2, and PIG3. To ascertain the change in transcriptional activity of p53, luciferase assay was per formed after co-transfecting p53 null human lung cancer H1299 cells with pWWP-Luc (containing a 2.4-kb genomic fragment from the human p21 promoter driving expression of luciferase) and pCMV-wild type p53 construct or empty vector. After 24 h of treatment with 1 pM FZ, an ~7-fold increase in luciferase activity was observed, confirming an increase in p53 transcriptional activity (Fig. 3E) . Western blot analysis of p53-regulated genes also showed an increase in the protein levels (Fig. 3jF) . In addition, when Western blot analysis for cyclin Bl, a gene associated with the G2/M phase of cell cycle, was per formed, a clear induction was observed ( Fig. 3G (i) ). Also, an in vitro kinase assay for CDI<2 revealed an increase in its activity 24 and 48 h after treatment ( Fig. 3G (ii) ). Therefore, the results indicate that cell cycle regulators and pro-apoptotic genes, including cyclin Bl, p53, and p21, were induced prior to cells undergoing apoptosis following FZ treatment.
FZ Inhibits the Proteasome Function-The majority of pro teins in the cell are degraded by ubiquitin-proteasome pathway, and inhibition of proteasomal function can markedly increase the stability of proteins in the cell. Also, proteasomal function is known to be inhibited in response to stress inside the cells. Therefore, we sought to explore if FZ exerts its effect through inhibition of proteasome function, which could lead to a myriad of downstream consequences, many of which have been impli cated in mediating cancer cell death.
Human lung cancer cell lines H460 and A549 were exposed to FZ, and chymotrypsin-like proteasome activity was meas ured using a model fluorogenic substrate, succinyl-Leu-LeuVal-Tyr-MCA, as described under "Experimental Procedures." As shown in with pd1 EGFP plasmid as described under "Experimental Procedures." 24 h post-transfection, cells were treated with cycloheximide (50 p.g/ml) and chased in the presence or absence of 5 pM FZ for different time periods. GFP fluorescence was observed under a Nikon fluorescence microscope. 8, following treatment, the cells were processed for Western blotting using GFP and /3-actin antibodies. C, H1299 cells were transiently transfected as described in A and treated with different doses of FZ. Cell lysates were subjected to immunoprecipitation {IP) using anti-GFP antibody followed by Western blot analysis {WB) using GFP and ubiquitin antibodies.
somal assays for post-glutamyl peptidyl-hydrolyzing and trypsin-like protease activities showed that FZ could effectively inhibit the protease function in a dose-dependent manner. Because FZ inhibited the proteasomal activity in cell culture, we tried to explore the possible mechanism of proteasome inhibi tion. We examined the direct effect of FZ on 20S proteasome activity. The purified 20S proteasome was incubated with vary ing doses of FZ in the presence of chymotrypsin-like, post-glu tamyl peptidyl-hydrolyzing, and trypsin-like protease sub strates, and protease activities were monitored. To confirm the results further, we looked for the global ubiquitylation status of FZ-treated cells as compared with untreated control cells. Because proteasome inhibition would block the degradation of several ubiquitylated proteins, it should lead to the increased accumulation of ubiquitylated forms of numerous proteins. Fig. 5A shows the increase in the accumulation of ubiquitylated derivatives of various cellular proteins following exposure to FZ in a dose-dependent manner. This result was confirmed by immunofluorescence using ubiquitin antibody (Fig. SB) . Again, an overexposed p53 blot showed multiple higher molecular weight bands corresponding to ubiquitinconjugated protein comparable with those seen in cells treated with known proteasomal inhibitor MG132 (Fig. SC) . To sub stantiate our results, we transiently transfected H460 cells with FLAG-ubiquitin plasmid and then treated them with different doses of FZ. Cell extracts were subjected to Western blot anal ysis using either anti-FLAG or anti-ubiquitin antibodies (Fig.  SD) . Results showed an increase in the levels of ubiquitylated proteins dose-dependently.
Hence, we inferred that the substantial induction of p53 observed earlier might also be attributed to its accumulation B 25
Con FZ TNFa FZ + MG132 MG132 TNFa + TNFa FIGURE 8. FZ blocks nuclear translocation of NFkB and results in downregulation of its transcriptional activity. A, H460 cells were either left untreated {a), exposed to 5 /u,m FZ for 4 h (b), exposed to FZ followed by 30 ng/ml TNFa for 1 h (c), or exposed to TNFa only (d). Following treatment, the cells were subjected to immunofluorescence using NFkB (p65) antibody. 6, A549 cells were transiently transfected with NFkB luciferase and pRL-SV40 plasmids. 24 h after transfection, cells were treated with 5 /lim FZ or 10 /ulm MG 132 for 4 h, followed by 30 ng/ml TNFa for 1 h, where indicated. Cells were then processed for dual luciferase reporter gene assay as described. *,P< 0.01 as compared with cells treated with TNFa only. C, H460 cells were treated with different doses of FZ for 4 h or TNFa for 30 min, and nuclear extracts were prepared and processed for EMSA as described under "Experimental Proce dures," using 32P-end-labeled oligonucleotide encoding an NF/<B-binding sequence as probes. A competition assay was performed using a 5-100-fold excess of unlabeled competitor. Error bars, S.D.
because of the proteasomal dysfunction. Altogether, these results indicate a proteasomal inhibitory activity of FZ.
FZ Treatment Causes a Decrease in the Turnover of a Model
Substrate of Proteasome-To further ascertain the activity of FZ as an inhibitor of proteasomal function, we used destabilized enhanced green fluorescent protein (dlEGFP), which is a known model substrate for proteasome with a half-life of 1 h. The pdlEGFP vector contains multiple proline, glutamic acid, serine, and threonine signal sequence in its C terminus, which identifies it as a substrate for proteasome-mediated degrada tion. Inhibition of the proteasome would result in an increased half-life of dlEGFP. H1299 cells were transiently transfected with the pdlEGFP expression plasmid, following which they were chased with cycloheximide in the presence or absence of 5
Fenbendazole, Antiproliferative Proteasome-targeting Agent /am FZ. Fluorescence microscopic observation showed that treatment with FZ significantly increased the half-life of dlEGFP protein (Fig. 6A) , which was confirmed by subjecting the cellular extracts to Western blotting using GFP and /3-actin antibodies (Fig. 6B ). This was reaffirmed by treating the cells with different doses of FZ following transfection with dlEGFP expression constructs and subjecting cell lysates to co-immunoprecipitation experiments using GFP antibody followed by Western blotting using ubiquitin or GFP antibodies. Expect edly, FZ treatment resulted in an increased accumulation of ubiquitylated dlEGFP proteins (Fig. 6C) . MG132 was used as a positive control.
Exposure to FZ Increases the Half-life of Various Cellular Proteasomal Substrates-Our results indicate that FZ acts as a potent proteasome inhibitor. This observation led us to exam ine more closely the stability of some important target mole cules involved in cell signaling, cell cycle regulation, and apo ptosis. We measured the half-lives of IkBck, p27Kipl, p53, and cyclin Bl.
First, we checked the effect of FZ on the accumulation and degradation of IkBck, a known target for proteasomal degrada tion. As shown in Fig. 7A , exposure to FZ caused an increase in the half-life of IkBck in A549 and H460 cells. A similar increase was observed in the half-lives of other proteasomal targets cyclin Bl, p27K,pl, and p53 (Fig. 7, B-D) . These findings were consistent with our earlier results wherein we showed stabili zation of p53 with increased half-life. AUGUST 
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The increase in half-life of IkBck is expected to result in the down-regulation of NFkB activity. Immunofluorescence for NFkB in H460 cells pretreated with FZ showed an inhibition in the nuclear translocation of NFkB after TNFa exposure (Fig.  8A) . Consequently, the transcriptional activity of NFkB was reduced upon FZ treatment, as determined by luciferase assay. Pretreatment with FZ resulted in an inhibition of TNFa-induced NFkB activity in A549 cells (Fig. SB) . Next, we performed EMSA for assessing NFkB DNA binding activity. Treatment with FZ led to a dose-dependent decrease in NFkB levels (Fig.  SC) . Taken together, these results suggest that FZ exposure results in a down-regulation of NFkB activity, which, in turn, is likely to be mediated via stabilization of iKBa. However, IKK inhibitor wedelolactone, which inhibits NFKB-mediated gene transcription in cells by blocking the phosphorylation and deg radation of IKBa, had no significant effect on FZ-induced apo ptosis (supplemental Fig. 4) . Therefore, it appeared that the hindrance of the prosurvival NFkB pathway may not be com pletely responsible for inhibition of cell proliferation by FZ.
FZ Increases ROS Generation in A549 Cells-It has been reported that proteasome inhibition increases intracellular ROS, which play a key role in apoptosis in some cancer cells. Apoptotic signals may disrupt the mitochondrial electron transport chain, leading to ROS production (29) . We examined ROS production in A549 cells treated with FZ by 2-dichlorodihydrofluoresein diacetate staining. As shown in Fig. 9, A duction as compared with control untreated cells. Significantly, a 2-h pretreatment with the antioxidant NAC was able to inhibit the ROS production by FZ, suggesting that ROS produc tion may have some role in FZ-induced apoptosis in these cells. ER Stress Response following FZ Treatment-Proteasome inhibitors have been shown to cause cell death via the ER stress-ROS pathway (30) . We examined the expression of a set of known unfolded protein response genes, namely BiP/GRP78, CHOP!GADDI53, IREla, ATF3, and NOXA, by RT-PCR (data not shown) and quantitative PCR. Analysis of real-time PCR data indicated that there was an ~2-4-fold increase in expres sion levels of most of these genes in response to 24-h FZ treat ment, whereas NOXA showed an ~ 11-fold increase (Fig. 10A) . Bortezomib and MG 132 were used as positive controls. Because the level of SEAP production has been shown to be inversely correlated with the induction of ER stress, the assay has been successfully used to detect and quantify ER stress in real time (31) . SEAP traverses the secretory pathway, and its activity can be detected at very low levels (0.2 pg/ml). Because SEAP is a secreted protein, medium supernatant can be assayed for SEAP activity. Most importantly, transfection of cells with SEAP does not, by itself, cause ER stress. When 293T cells were transiently transfected with SEAP vector and exposed to FZ for 24 h, there was a dose-dependent decrease in the accumulation of SEAP protein in the medium (Fig. 10B) .
IRE1 is a transmembrane receptor involved in the initiation phase of ER stress-induced apoptosis. Upon activation, the 30636 JOURNAL OF BIOLOGICAL CHEMISTRY endonuclease activity of IRE1 removes a 26-nucleotide intron from the XBP1 mRNA, generating a frameshift splice variant (sXBPl), which encodes a stable, active transcription factor (32) . We detected this splicing of XBP1 mRNA by semiquantitative RT-PCR using primers specific for XBP1 that can detect both unspliced and spliced isoforms. Our results show the two isoforms, although the spliced variant was not as marked as in the case of bortezomib, which was included as a positive control along with MG132 (Fig. 10C) .
Upon ER stress, IRE1 stimulates p38, causing activation of JNK. We observed an increase in phosphorylated JNK and p38 MAPK levels and a reduction in BCL2 levels after FZ treatment (Fig. 10D) . Up-regulation of CH OP/GADDI S3, as well as JNK activation by ER stress, is known to repress BCL2 gene expres sion and execute apoptosis by the activation of proapoptotic BCL2 proteins in the cell (33) . Taken together, these results suggest that ER stress may be involved in FZ-mediated cell death. Interestingly, treatment of cells with translational inhib itor cycloheximide, which relieves ER load, was able to abrogate FZ-induced cytotoxicity (Fig. 10, E and F) . This finding is con sistent with earlier reports showing a protective effect of cyclo heximide on cells under ER stress (34, 35) and further supports our notion that FZ-induced cell death is ER stress-dependent.
FZ Induces Mitochondrial Membrane Depolarization, Cyto chrome c Release, and Activation of Caspases-Proteasomal inhibition is known to induce the mitochondrial pathway of apoptosis, and because we also observed a marked induction of VOLUME 287-NUMBER 36-AUGUST31,2012 . B, after treatment as described in A, the cells were subjected to immunofluorescence using cytochrome c antibody. C, H460 cells were plated onto 35-mm tissue culture plates, and on the following day, the cells were treated with different doses of FZ for 24 or 48 h. The cells were then collected and processed for immunoblotting using caspase-3 and caspase-9 antibodies. D, H460 cells were treated with different doses of FZ or 10 fxm MG 132 for 48 h, and cell extracts were then prepared and processed for the caspase-3 activity assay using fluorogenic substrate as described under "Experimental Procedures." E, H460 cell extracts were prepared as described in C, and Western blotting was performed using anti-PARP antibody. Error bars, S.D.
p53 by FZ, we proceeded to check whether the intrinsic path way of apoptosis was activated in response to FZ. To monitor the effect on mitochondrial membrane potential, we used JC-1, a voltage-sensitive fluorescence dye that forms aggregates in the polarized mitochondria, which fluoresce red but become green as monomers, which diffuse out in the case of depolarized membrane. The treatment with FZ resulted in a decrease in the mitochondrial membrane potential, as evident from the loss of red-dotted mitochondrial staining (Fig. 1L4) . FZ also induced the cytochrome c release from the mitochondria, as detected by immunofluorescence using cytochrome c antibody (Fig. 11.B) . Because the release of cytochrome c from mitochondria finally results in the activation of caspase-3, we next examined its level by Western blotting. As shown in Fig. 11C , Western blot for pro-caspase-3 upon FZ exposure showed a decrease in its level that could be correlated with a corresponding increase in its activity measured using a fluorogenic substrate (Fig. 11D) . Further, treatment with 1 /xm FZ for 24 and 48 h resulted in cleavage of the 115-kDa PARP into an 85-kDa product (Fig.  WE) . The above results lead to the conclusion that FZ activates the cytochrome c-mediated intrinsic pathway of apoptosis in these cells. However, pretreatment with broad-spectrum caspase inhibitor Z-VAD-FMK had no effect on FZ-induced cell death. Cells pretreated with Z-VAD-FMK could not be morphologically distinguished from cells exposed to FZ alone (Fig. 12, A-D) . Because caspase inhibition has been shown to be ineffective in preventing ER stress-mediated cell death (36, 37) , this result is in agreement with our data indicating the role of ER stress in FZ-induced apoptosis.
DISCUSSION FZ belongs to a class of broad-spectrum anthelmintics, the benzimidazoles, which have a high therapeutic index. The key factor to which the success of benzimidazoles as effective ant helmintic agents is attributable is their selective toxicity to hel minths and high degree of safety toward normal human cells. This has been explained previously on the basis of two different phenomena: by selective targeting of parasitic tubulin by benz imidazoles due to their structural refinement or by differences in the metabolic and detoxification pathways between mam mals and target parasites (10) (11) (12) 38) . Earlier, a few compounds belonging to this class have been shown to act as effective anti tumor agents, although the molecular mechanism remains elu sive. In this study, we show that fenbendazole acts as a growth AUGUST31,2012-VOLUME 287-NUMBER 36 inhibitor and causes apoptotic cell death in human lung cancer cell lines. Appropriate, targeted proteolysis is essential for cellular function and homeostasis. In eukaryotic cells, the ubiquitin proteasome pathway is the central non-lysosomal pathway for protein degradation (39) . The vast majority of proteins are selectively degraded by the ubiquitin-proteasome system, which, in turn, makes it crucial to the cell's existence. The dynamic balance of substrate ubiquitylation and degradation plays an important role in cell cycle progression and cell sur vival (39, 40) . It is, therefore, self-evident that the dysfunction of this pathway will promote cell death. Predictably, the pharma cological inhibition of proteasome function has been found to induce dual apoptotic signaling pathways, depending on the specific cellular context, and various proteasome inhibitors have been propelled toward therapeutic applications, bortezomib (Velcade) being the first clinically approved small mol ecule proteasome inhibitor (41) . However, bortezomib has 30638 JOURNAL OF BIOLOGICAL CHEMISTRY been reported to have no anti-tumor activity in a non-small cell lung cancer-derived xenograft mouse model (3). After bort ezomib, several second generation proteasome-targeting agents like NPI-0052 (salinosporamide A), MLN9708, CEP18770 (phase I), argyrin A, and carfilzomib (phase III) have entered clinical trials (1,41-45). Our results indicated that FZ acts as an inhibitor of proteasomal function and results in cell death by activating the mitochondrial pathway.
First, we have shown that the exposure to FZ inhibits the cellular proteasome function dose-and time-dependently and leads to accumulation of ubiquitylated derivatives of various cellular proteins, including p53, which, in turn, leads to apopto sis via the mitochondrial pathway. This was further confirmed by inhibition of degradation of destabilized enhanced green fluorescence proteins, a model substrate of proteasome, and also various other cellular substrates of proteasome like IkBcx, p53, and cyclin Bl. Finally, we have demonstrated that FZ treat ment results in changes in mitochondrial membrane potential, However, the broad-spectrum caspase inhibitor Z-VAD-FMK did not substantially rescue the cells from FZ-induced cell death, suggesting the existence of an alternative, caspase-inde pendent mechanism that is instrumental for the cell-killing effect of FZ.
Our results reveal that in response to FZ treatment, the cells first undergo G2/M arrest followed by apoptosis. p53 activation has been previously reported to be a key event in cell death caused by proteasomal inhibitors (46) . Because FZ treatment results in marked induction of p53 and corresponding up-regulation of its target genes, this could contribute to the cells undergoing cell death via the mitochondrial pathway. There fore, FZ-induced proteasomal dysfunction could indirectly cause mitochondrial cytochrome c release. Besides p53 and its target genes, proteasome inhibition can also modulate the expression of other proteins implicated in the apoptotic path way as well as in cell growth and survival pathways (47, 48) . This alteration in the degradation of various cellular proteins would result in a change in their expression levels, which, in turn, is likely to affect cell survival and promote apoptosis. In addition, we also report inhibition of NFkB transcriptional activity after FZ treatment. This can possibly be attributed to the stabiliza tion and increase in half-life of IkBcx, which is known to inhibit the NFkB cell survival pathway. We provide evidence that FZinduced proteasomal dysfunction prevents the degradation of IkBu and thereby blocks the nuclear translocation and transac tivation of NFkB. In this context, it might be noted that the NFkB pathway, which may play a key role in protecting cells from oxidative stress is known to be disabled by proteasome inhibitors (49, 50) .
FZ-induced ROS generation could be associated with the transcriptional activation of ROS-related genes. Our data show PIG3 induction upon FZ treatment. PIG3 is a p53-inducible gene homolog of oxidoreductase and is reported to be associ ated with p53-induced elevation of ROS production (51) .
Proteasomal inhibition is likely to accumulate mitochondrial damage and generate oxidative stress inside the cell (52) . Oxi dative stress can, in turn, affect proteasome function either by producing excessive levels of damaged proteins, causing unfolded protein response or by reducing the levels of ATP production. Proteasome inhibitors have been previously reported to elicit ER stress response (53, 54) . Certain com pounds selectively kill cancer cells by induction of ER stress-ROS, because cancer cells are expected to rely strongly on the ROS stress response pathway as compared with normal cells (55-58). Altogether, our results indicate that FZ induces cyto toxicity in cancer cells via impairment of proteasomal function and induction of unfolded protein response.
The ubiquitin-proteasome system is integral to cellular pro tein homeostasis. The growing recognition of the fundamental importance of this pathway to normal cell function and in dis ease has prompted an in depth search for small-molecule inhib itors that selectively block the function of these pathways. Therefore, we propose FZ as a novel drug candidate that targets the ubiquitin-proteasome pathway and effectively kills cancer 
Introduction
There are about 158 million water buffaloes in the world, and that 97% of them (approximately 153 million animals) are in Asia. Buffaloes contribute about 15% of the total world milk supply. Buffalo milk contains higher total solids (protein, fat, minerals) of 18-23% as compared to 13-16% in cow milk. This confers advantage in the preparation of specialized cheese, curd and other dairy products [1] . With selective breeding, improved manage ment and the establishment of more dairy herds, milk yields in buffaloes are increasing. While a plethora of information is available on mammary gland biology and lactation function in cows [2] , information on buffalo mammary gland biology is scarce. The mammary gland is a complex, highly specialized tissue with diverse physiological, biochemical and immunological functions, which has evolved to provide nutrition to the neonate. The mammary gland undergoes cyclic changes of proliferation, lactation and involution with respect to the reproductive status of the animal. The structural architecture of mammary gland is made up of secretory tissue and ductular system supported by the connective tissue. The structural unit of the secretory tissue called acini is made up of secretory epithelial cells lining the lumen and myoepthelial cells surrounding the epithelial cells. The mammary epithelial cells are involved in the synthesis and secretion of milk proteins [3] . Milk protein synthesis, cell growth and differentiation are regulated by the peptide and steroid hormones [4] , cell-cell interactions [5] and cell-extra cellular matrix (ECM) interaction [6] . The cellular complexity makes it difficult to dissect out the contribution of different components in the functioning of the mammary gland. In addition, the commercial value of milk has generated great interest in understanding the mechanisms of milk production and response of mammary gland to pathogenic infections.
The molecular mechanisms of developmentally and hormonally regulated milk protein synthesis had been investigated on primary culture and mammary epithelial cell lines of murine origin. Although the development and metabolism of murine and bovine mammary epithelial glands are comparable there is substantial Table 1 . Primer sequence and reaction conditions for PCR amplification. difference in milk composition and signalling mechanism of lactogenic hormone. While P-lactoglobulin is expressed in bovine, the same is absent in rodent mammary gland. Furthermore, the main lactogenic hormone signaling pathway i.e, jak2-stat5 pathway is prominent in rodent while the same is inconsistent in bovine [7] . Moreover, the involution in ruminant mammary gland is less extensive than that of rodents [8] . The physiology of caprine mammary gland is different from bovine in mammary secretion mechanism, which is apocrine in caprine and merocrine in bovine. The mammary gland regression and decreased milk production is associated with a decrease in the number of mammary epithelial cells in caprine [9] in contrast to the loss of differentiated function and a minimal decrease in cell number in bovine [10] . Hence, an in-vitro model retaining the species-specific mammary gland functions is of great importance in the study of development, differentiation and involution of mammary gland. Mammary epithelial cells can be used as expression systems for production of transgenic proteins. Transgene expression of target protein in milk has several advantages over expression in prokaryotic and yeast systems [11] . Hence it is desirable to use a fully functional and transfection efficient mammary epithelial cell line as in vitro screening system for superior transgenes. A few immortalized mammary epithelial cell lines, induced spontaneously and by transfection of viral gene constructs have been established till recently. Spontaneously immortalized mammary epithelial cell line of bovine BMEC+H [12] and HH2A [13] , ovine NISH [14] , porcine SI-PMEC [15] have been established. However, only a few cell lines express lactation specific proteins. The bovine mammary epithelial cell lines ET-C [16] , BME-UV [17] and MAG-T [18] have been established by stable integration of simian virus large T antigen (SV40LTA) gene to induce immortalization. However, the process of immortalization may change the physiological pathways in transformed cell lines; hence the primary cell lines are more likely to represent in vivo conditions, maintaining organ specific functions and signal transduction pathways [19] .
Although both cattle and buffaloes belong to Bovidae family, species-specific differences exist between these two species. Therefore, for functional studies involving buffalo mammary gland, use of buffalo mammary epithelial cell line is more appropriate than using cell lines from other related species like cattle. Till date no buffalo mammary epithelial cell line is available. Breast cancer research is an ever increasing area which needs various cell model systems for understanding the function of various biomolecules. Occurrence of mammary carcinoma is rare in large ruminants, specifically in cows and buffaloes [20] , Establishment of buffalo mammary epithelial cell line will be another model system for the research communities to study the complex phenomenon of breast cancer in general and bovine mammary carcinogenesis, in particular. In the present investiga tion, we report the establishment and characterization of a buffalo mammary epithelial cell (BuMEC) line. 
Materials and Methods
Ethics Statement
No ethical approval was needed for tissue collection because the tissue was obtained from the Idgah Slaughter House, New Delhi, India and the animals were not killed for scientific research.
Isolation and Culture of Buffalo Mammary Epithelial Cells
Buffalo mammary gland tissue was obtained from local slaughterhouse (New Delhi, India) for isolation of BuMEC. We followed essentially the same protocol used by Ahn et al. [21] for isolation of BuMEC with minor modifications. Briefly, mammary parenchyma tissue was collected from a disease-free buffalo udder after slaughter and transported aseptically to the laboratory in ice in sterile HBSS (Sigma, USA) containing 100 U/ml penicillin, 5 pg/ml streptomycin and 50 ng/ml amphotericin (HBSS-PS). The tissue pieces were trimmed of connective tissue, including fat and washed three times with HBSS-PS. The tissue was minced with sterile blade and digested with 0.05% collagenase (Sigma, USA), 0.05% Hyaluronidase (Sigma, USA) for 3 h at 37°C. The digested tissue were further treated with 0.25% trypsin EDTA (Sigma, USA), 1% Dispase (Stem cell Technologies, USA) and DNasel (Stem cell Technologies, USA) at a concentration of 1 mg/ml for 30 min at 37°C and filtered through 40 |1 cell strainer (Stem cell Technologies, USA). The filtrate was centri fuged at 80 xg for 1 minute. The pellet was washed three times with phenol red free DMEM-F12 (Sigma, USA) containing 10% FBS. The cells were seeded at a density of 2xl0J cells/35 mm dish (Nunc, Denmark) in growth medium, which was containing DMEM/F12 supplemented with 5 pg/ml bovine insulin (Sigma, USA), 1 pg/ml hydrocortisone (Sigma, USA), 1 pg/ml apotransferrin (Sigma, USA), 10 ng/ml EGF (Sigma, USA), 10% FBS, 100 U/ml penicillin, 5 pg/ml streptomycin and 50 ng/ml am photericin. For induction of milk protein expression, BuMECs were grown in the growth medium supplemented with 5 pg/ml Prolactin (Sigma,USA). The cells were cultured in an incubator at 37°C under 5% CO2. For cryopreservation, 106 cells/ml were suspended in freezing medium constituting 70% DMEM/F 12, 20% FBS (Hyclone, USA) and 10% DMSO (Sigma, USA). Cell suspensions were distributed into 1 ml aliquots in cryovials and stored in liquid nitrogen. We used selective trypsinization steps to enrich the mammary epithelial cells (MECs) preferentially and remove the fibroblast cells from the primary culture. For selective trypsinization 0.25% trypsin-EDTA (Sigma, USA) was added to the confluent monolayer of heterogeneous population of cells and allowed to act for three min at 37°C. The trypsinization was stopped by adding fresh growth media, and the detached fibroblast cells were removed. The cells in monolayer which remained attached to the surface were allowed to grow by addition of fresh growth medium. The cells were subjected to 7 continuous passages for selection of homogeneous population of BuMECs. The BuMECs were routinely evaluated for sterility by growing them in antibiotic free media. The cells were also tested for incidence of mycoplasma contamination using Myco Alert Mycoplasma de tection kit (Lonza, USA).
Growth Characteristics on Plastic Substratum
The 
Growth on Collagen Matrix
Collagen gels were prepared using bovine skin collagen Type I (Sigma, USA) following the manufacturers instruction. Briefly, 300 pi of neutralized bovine collagen type I per well at a concentration of 2 mg/ ml was used to coat 24 well tissue culture plates. BuMECs at a concentration of 2xl04 cells in growth medium/dish was layered over the basal coating and allowed to attach for 8 h. After attachment the growth media was aspirated and overlaid with collagen solution. Cells were grown in growth medium with subsequent changes in every 48 h for up to 10 days. Morphological changes observed in BuMECs were photographed using phase contrast microscope (Nikon Ti Eclipse, Nikon, Japan). To study the cellular organization of the structures which developed in collagen matrix, the cells were stained with nuclear counter staining dye propidium iodide (500 nM) after fixing the cells with ice-cold methanol. The cellular structures were photographed using phase contrast fluorescence microscope (Nikon Ti Eclipse, Nikon, Japan).
Senescence Associated p-galactosidase Assay (SA-p-gal)
SA-P-gal assay was performed using senescence cells histochemical staining kit (Sigma, USA) following manufacturer's protocol. Briefly, monolayer of BuMECs at passage 15 and 60, skin fibroblast cells (senescent stage-positive control) and CHO-K1 cell (negative control) were washed with 1 xPBS and fixed with 1 xfixation buffer for 7 min at room temperature. The cells were then washed 3 times with 1 xPBS. Following the washing, the cells were incubated for 12 h at 37°C in staining solution. Photographs of stained cells were acquired using a phase contrast microscope (Olympus 1x51, Japan). Stained cells were counted in 5 high magnification fields (x400) and the extent of senescence was expressed in percentage.
RNA Extraction and cDNA Synthesis
Total RNA from mammary tissue, BuMECs and skin fibroblast cells (negative control) was prepared using TRIzol (Invitrogen, USA) according to manufacturer's protocol. RNA integrity was assessed in 1.5% agarose gel electrophoresis by observing rRNA bands corresponding to 28S and 18S. Possible genomic DNA contamination in RNA preparation was removed by using DNA free kit (Ambion, USA) according to manufacturer's protocol. Purity of RNA was checked in UV spectrometer with the ratio of the OD at ^.260 and A.280 being >1.8. 1 |Hg of DNA free RNA was used for first strand synthesis for each sample. Primers for pcasein (CSN2), butyrophilin (BT1JV1A1), K-casein (CSN3), lactoferrin (LIT) and GAPDH were designed using primer 3.0 software (Table 1) excitation and emission filters. DAPI (300 nM, Sigma) was used as nuclear counter stain.
Western-Blotting
Total protein was isolated from BuMECs between passages 10 and 15, fibroblasts cells (negative control) and lactating mammary tissue (positive control) using Qproteome mammalian protein isolation kit (Qiagen, USA). 'Total protein in the lysates was quantified by Bradford assay. Five pi of buffalo milk was mixed with SDS sample buffer and heated in boiling water for 10 minutes. An aliquot of this preparation was used as positive control for casein detection. For detection of secreted casein in conditioned medium, culture super natants were removed and concentrated 10 fold. The lysates and culture supernatant were separated in 12% polyacrylamide gels and transferred to PVDF membrane using semi-dry transblot apparatus (GE, USA). The membrane was blocked in NAP blocker (G Biosciences, USA) in TBST for 1 h. Transferred membranes was incubated with primary antibodies of bovine casein (1:5000), and Actin (1:2000) (loading control) diluted in TBST and incubated overnightat4°C.Themembranewaswashed3x 15 min using TBST and then incubated with diluted (1:4000 in TBST-NAP blocker) ECL plex Cy 5 Dye conjugated secondary antibody (GE, USA) for 1 h at room temperature. The membrane was washed with TBST 3x15 min and scanned for fluorescence detection using Typhoon Trio -I-scanner (GE, USA).
Chromosome Analysis
Exponentially growing BuMECs at early passage (passage 20) and late passages (passage 50) were incubated with colchicine (10 pg/ml) (Sigma, USA) for 6 hours. The cells were trypsinized with 0.25% trypsin and treated with hypotonic KCL soluti (56%) for 30 minutes at 37°C. The cells were centrifuged at 200 for 10 minutes for preparing the cell pellet. 'The cells af resuspension were fixed with ice-cold methanol: acetic acid (3 for 30 minutes at -2CTC and the same process was repeated twi< Finally, the cells were resuspended in 0.5 ml of with ice-cc methanol: acetic acid (3:1) and dropped on to an ice-cold glj slide. 'The slides were dried and stained with Giemsa stain for minutes, washed with distilled water and dried at roc temperature. The chromosomes were visualized with pha: contrast microscope and analysed using cytovision genus softwa (Applied Imaging, USA) for karyotyping. A total of 50 metapfu spreads at passage 20 and passage 50 were counted, and the moc chromosome number was determined.
Results
Establishment and Growth Characteristics of BuMECs
Primary culture obtained from enzymatic digestion of bufU mammary tissue contained heterogeneous population of epithel and fibroblast-like cells when cultured on plastic substratum. T freshly isolated cells after 5 6 days of growth on plastic substratu developed as mixed population of cuboidal shaped epithelial ce surrounded by spindle shaped fibroblasts cells (Fig. 1-A) . Furth passages with selective trypsiniszation resulted in the removal fibroblasts and yielded a homogenous population of cuboic BuMECs. When cultured at low density BuMECs formed islan (Fig. 1 B) and exhibited typical cobblestone morphology < reaching confluency (Fig. 1 C) . In early post confluency (3 5 da' dome shaped structures emerged (Fig. 1 D) which constitut a layer of cells raised above the plastic substratum. 'This w Time (Days) further confirmed by phase contrast microscopic images of domes with the objective focussed at different planes; once at monolayer ( Fig. 1-E) and then on the top of dome (Fig. I F) . Few domes in the monolayer were obsereved to be connected by unique interconnecting structures (Fig. 2-A and Fig. 2-B) . groups in bovine [22, 23] , porcine [24J and caprine [25] . Furthermore, we observed a 4 to 5 fold increase in the formation of domes in hormone treated BuMECs in comparison to BuMECs without hormone treatment (Fig. 4) . Growth curve analysis of BuMECs on plastic substratum revealed a population doubling time of about 36 48 hours without any substantial changes between passage 10 (early), frozen thawed MECs at passage 25, and passage 60 (late passage). BuMECs reached conflueney at day 6 after seeding ( Fig. 5) . Contact inhibition among cells was observed at post confluent stage that was evident from the floating dead cells in the medium. BuMECs showed all the characteristics of normal cellular phenotype without any sign of transformation. The non transformed state of BuMECs was further confirmed by soft agar colony formation assay. BuMECs at passage 50 did not form colonies in soft agar in the presence of hormone supplemented media after 15 days in culture. The experiment was repeated twice with BuMECs at different late passages (55 and 60) with consistent results (Data not shown). Senescence Associated p-galactosidase (SA-p-gal) assay was carried out on early passage (passage 10) and late passage (passage 60) BuMECs to assess the level of senescence. BuMECs showed staining in around 10% of cells (Fig. 6) . The SAp-gal positive cells stained blue of which the stain was mostly confmed to the cytoplasm. The senescent cells showed enlarged morphology and had more number of vacuoles (Fig. 6 B) . Till date we have maintained BuMECs in continuous culture for more than 60 passages without evidence of any change in growth properties and senescence.
The influence of tissue microenvironment on growth and morphology of BuMECs was studied by growing BuMEC on collagen Type I matrix. The attachment of BuMECs to collagen matrix was found to be faster than on plastic substratum. After 48 h of culture on collagen matrix BuMECs developed cellular aggregates ( Fig. 7 A and 7 C) unlike on plastic substratum (Fig. 7  B) . After continuous culturing for 96 h, formation of "duct-like" structures inter-connecting these cellular aggregates were ob served. Counter staining of the nuclei of BuMECs with propidium
• » PLoS ONE | www.plosone.org iodide in these inter-connecting structures further confirmed th< formation of duct-like structures with presence of lumen (Fig. 7  D) . Further, our preliminary studies of growing BuMECs or surface ofMatrigel (BD Bioscience, USA) revealed development o duct-like structures with apparent lateral bud (Fig. SI A) . We alse observed formation of acini-like spheres when BuMECs wer< embedded and grown in the Matrigel for 10 days (Fig. SI B, C and D). These data suggest that BuMECs undergo morphologica differentiation in the presence of exogenous matrix.
Cytoskeleton Expression
The BuMECs were stained with anti-cytokeratin 18 antibody tc detect expression ofcytokeratins, which are specific to epithelial cell: and with anti-vimentin antibody to detect vimentin, which is specific for stromal cells like fibroblast cells. Almost all the BuMECs revealec strong positive staining for cytokeratin 18 (Fig. 8 A) after 5 days pos seeding that confirmed their epithelial origin. Immuno staining o cytokeratin revealed intense network of cytokeratin intermediate filaments with clear intercellular tonofilament junctions. These networks of cellular structures are vital for intercellular communica tion and polarity [19] . In contrast a majority of BuMECs were noi stained by anti-vimentin antibody except very few cells, which stainec lightly (Fig. 8 B) with evidence of filament degradation. The staining in these cells was largely restricted to the periphery part of the cytoplasm. Negative control experiment with Mouse IgG isotype revealed no specific staining of cells (Fig. 8 C) . The experiment wa: repeated three times with reproducible results.
Milk Protein Expression
Analysis of expression of milk protein in mammary epithelial cell is important for developing optimal culture conditions and establishing the status of functional differentiation in vitro. The protein synthesiz ing property of the BuMECs was analyzed by reverse transcriptase PCR (RT-PCR), western blotting and immunocytochemistry Expression of mRNA for CSN2, CSN3, BTN1A1 and LTF were determined by RT-PCR. Robust amplification of the transcripts foi CSN2, CSN3, BTJV1A1 and LTF was observed in BuMECs cultured in the presence of insulin, hydrocortisone and prolactin between passages 10 and 20 ( Fig. 9) . Western blot analysis revealed that lysate of BuMECs, mammary tissue and milk reacted positively with anti casein antibodies while no reactivity was observ ed in the lysate of fibroblast cells (negative control) (Fig. 10 A) . We observed casein bands of slightly low molecular weight in BuMEC (Fig. 10 A, Lane C) compared to casein bands in milk ( Fig. 10 A Lane A) and mammary tissue ( Fig. 10 A, Lane B) . The variation in the size of the caseins in BuMECs may be due to differences in post translational modification between intracellular and secreted form of the casein which was earlier reported in mouse mammary' epithelial cell line [26) . Casein secretion by the cultured BuMECs in growth medium was examined by western blotting of concentrated conditioned medium using anti casein antibody. Weak bands (Fig. 10 B) corresponding to milk casein (Lane A) were detected in BuMEC conditioned media (Lane C). The lanes B and D represent the negative controls which are concentrated growth medium and conditioned medium from skin fibroblasts respectively. Immunocytochemistry of BuMECs showed positive staining for caseins with comparatively stronger signals in PLoS ONE | www.plosone.org 9 cells associated with domes ( Fig. 11 A and Fig. 11 B) , Negative control experiment with rabbit IgG isotypes revealed no staining ( Fig. 11 C and Fig. 11 I) ).
Chromosome Analysis
Chromosome analyses of early passage (passage 20) and late passage (passage 50) BuMECs revealed normal diploid (2n = 50) chromosomes number which are specific for water buffalo [27) . Representative images of metaphase spread and karyotype are shown in Figure 12 .
Discussion
The objective of this study was to establish a buffalo mammary epithelial cell line and characterize its functional properties. With no established mammary epithelial cell line available for buffalo, this study assumes great significance because of its importance in the study of mammary specific gene functions in buffaloes and other related species. The enzymatic digestion of mammary gland tissue yielded a heterogeneous population of cells with both epithelial and fibroblast-like cells. The BuMECs showed the properties similar to bovine [21] and caprine [19] MECs which grew on plastic substratum and remained sensitive to lactogenic hormones. However, these properties were in contrast to the observations made by other groups in bovine [28, 29] and caprine [30] who reported that collagen was essential for the growth and protein production in mammary epithelial cells.
BuMECs exhibited cobblestone morphology similar to mam mary epithelial cells from other species and formed islands when seeded at low density. At post confluent stages BuMECs formed dome-like structures, which appeared sporadically throughout the monolayer. It has been reported that the dome-like structure develops due to accumulation of fluid under the epithelial cell monolayer when they grow on plastic substratum [31] . This phenomenon corresponds to the cellular changes occurring in vivo when tubules and alveoli are developed in the mammary gland during pregnancy [32] . Formations of spontaneous dome structures in BuMECs grown on plastic substratum suggest that these cells undergo contact mediated differentiation and secrete basement membrane components. MEC lines have been reported to show dome-like structures in bovine [22] , ovine (NISH) [14] , human [33] and in rat in the presence of DMSO [34] . The SV40 larger T antigen induced immortalized MAC-T cells of bovine origin have also been reported to form dome-like structures when cultured on collagen [18] or when co-cultured with bovine myoepithelial cells [35] . Interestingly the dome formation in BuMECs occurred at a higher frequency when grown in medium containing insulin and hydrocortisone in comparison to the cells grown in basal growth medium. Hormone induced cell polarisa tion and directed secretion of proteins to basal side of MECs have been reported in mouse [36] and ovine [37] . One of a unique feature in BuMECs was the development of interconnecting structures (Fig. 2 A, 2 B and 2 C) in between domes, which further showed branching pattern (Fig. 2 D) and similar cellular organization ( Fig. 2 E and 2 F) which were observed in the dome. A possible reason for this may be the extension of contact mediated differentiation of BuMECs in a defined direction from one dome to another in the monolayer. This characteristic feature of BuMECs has not been reported in other species.
Growth of BuMECs on plastic substratum revealed a population doubling time of 36 48 h (Fig. 5) representing the characteristics of normal non-transformed phenotype. Similar observations have been reported in bovine MECs [38] . However, Hu et al. [22] observed a doubling time within 72 h in MECs derived from Chinese Holstein cows. To ascertain the effect of frozen preservation on viability of BuMECs, we compared the growth characteristics of unpreserved early passage (Passage 10), frozen thawed cells at passage 25 and at passage 60. Growth curves of all the three BuMECs at different passages showed a typical "S" sigmoid curve wherein during the first three days of latent phase, the growth rate was slow. In the next three days, there was an increase in the growth rate of BuMECs followed by a steady phase. Growth pattern of BuMECs at early, late passage and frozen thawed conditions suggests that the established cell line maintain identical and favourable growth characteristics even after cryopreservation. Therefore, frozen preservation did not have any effect on the proliferation of isolated BuMECs. Similar observations have been reported in bovine [35] , caprine [19] and porcine [15] .
Bovine MECs have been reported to spontaneously overcome the proliferation barriers leading to immortalization [38] . To assess the proliferative characteristics and the extent of senescence in BuMECs, we performed SA-p-gal staining at passage 60. Immortalization is a process where cultured cells escape senes cence and acquire the ability to grow indefinitely [39] . Around 10% of the BuMECs stained positive for SA-p-gal staining at passage 60. The staining of cytoplasm of senescent BuMECs was evident from the morphologically enlarged and flattened cells with PLoS ONE www.plosone.org more vacuoles (Fig. 6-B) . Presence of very few senescent cells among a largely populated viable BuMECs suggests that the cells have undergone random transformation events leading to possible immortalization. Spontaneously immortalized bovine MECs have been reported to maintain normal morphology and proliferation characteristics with 10% of the cells being positive for SA-(3-gal staining, which constituted non-immortal cells [40] . Classical features of senescence in Human mammary epithelial cells show flat morphology, presence of vacuoles and positive staining for senescence-associated p-galactosidase (SA-p-gal), a marker for senescence [41] .
To assess the differentiating capacity of BuMECs the cells were grown on attached collagen type I matrix. The morphological differentiation of BuMECs to duct-like and acini-like structures on attached collagen gels provide evidence for their responses to microenvironment (Fig. 7) . To ascertain the formation of ducts, these structures were counter stained with propidium iodide.
Interestingly the acini-like structure contains more nuclei and duct-like structure shows a clear arrangement of stained nuclei along its sides suggesting the formation of wall and lumen. This observation is further supported by the development of duct-like and acini-like structures in Matrigel (Fig. SI: A D) . However, an absolute demonstration of duct-like structures would need a crosssectional view, which otherwise remains putative. Different MEC lines from different species viz, bovine [18] , caprine [19] and ovine [37] , mouse [42] , human [43] have been found to undergo collagen mediated morphological and functional differentiation resulting in duct and mammospheres. Integrins play a significant role in cell attachment, spreading and migration in vitro. Human normal MECs have been reported to form ridges and ball-like structure when collagen fibrils were added to mammary epithelial cells [44] which results due to integrin mediated morphogenesis.
Cytoskeleton expression is important in identifying epithelial cell lineage. Though the established BuMECs had epithelial [45] . It has been reported that cytokeratin filaments appear as interconnected bundles in the cytoplasm. The cytokeratin network is denser around the nucleus, cytoplasmic vesicles and in the periphery of the cell where the filaments run parallel to the cell surface, which after several subcultures may reduce to the area surrounding the nucleus [46] . Cytokeratin 18 is normally associated with simple epithelium and all luminal epithelial cells of human mammary gland. Positive reaction of BuMECs with anti-cytokeratin 18 antibody indicated their luminal epithelial lineage. We further analyzed myoepithelial cells contamination at early and late passages by western blot for a-Smooth muscle Actin (SMA), which is specific for myoepithelial cells in mammary gland. We did not detect a-SMA in BuMECs, which confirmed the absence of myoepithelial cells (data not shown). Our observation in BuMECs is in line with the reported expression of cytokeratin 18 in bovine [12] and human luminal MECs [47] . In contrast, we observed very low level staining of BuMECs with vimentin. The staining for vimentin in BuMECs was atypical with filaments largely confined to the periphery of the cytoplasm and showing fragmentation ( Fig. 8-B ). This observation was similar to earlier report in bovine [12] and differs from caprine [19] and bovine [22] where the vimentin staining was predominantly perinuclear with filament degradation. Although the exact cause of expression of vimentin in MECs is not known it has been suggested that induction of vimentin occurs as a result of culture adaptation, such as monolayer cultivation versus three-dimensional culture and in creased growth rate [48] . Casein secretion is considered as an important feature of mammary epithelial cells. Differentiation of MECs is character ized by expression of milk protein such as p-casein, whey acidic protein and milk fat [49] . Milk fat droplets are secreted from MECs by a budding process in which droplets of triglyceride formed in the cytoplasm are gradually enveloped by a layer of apical plasma membrane called milk fat globule membrane (MFGM). Butyrophilin (BTJV1A1) an acidic glycoprotein com prises over 40% by weight of total protein of bovine MFGM [50] and is specific to mammary tissue and only expressed at high levels on the apical surfaces of secretory MECs during lactation [51] .
Expression of butryophilin (BTJV1A1) and p-casein (CSN2) are considered to be the response of the mammary epithelial cells to hormonal induction [22] . Amplification of the transcripts of CSN2, CSN3, BTN1A1 and LTF by RT-PCR in BuMECs in the present investigation suggested that the cells were functionally differenti ated having normal secretory functions. The transcripts for CSN3
were detected consistently at all stages even in the absence of prolactin induction. Similar observation has been reported in bovine MECs where C&N3 expression was less responsive to prolactin, and expression was observed even in the absence of prolactin. Furthermore, CSJV3 was highly expressed followed by CSM1S1 and CSJV2 [6] . Lactoferrin expression was detected in BuMECs even in basal growth medium without hormonal supplements. This suggests that BuMEC had a normal secretory function. Similar findings have also been reported in porcine MEC model [52] . The MEC line to be used for studying mammary gland biology should have the in vivo properties of lactogenesis.
Presence of casein in BuMECs was also confirmed by western blotting which indicated their functional differentiation. All the three forms caseins such as CSN1, CSN2 and CSN3 were observed as three distinct bands in Western blot (Fig. 10-A) . We also observed casein in the conditioned medium (Fig. 10-B) .
We further examined the production of casein in BuMECs by imunocytochemistry for cells grown on the plastic substratum in the presence of lactogenic hormones. Observation of positive immunostaining for casein in BuMECs (Fig. 11-A and Fig. 11-B) and relatively stronger signal for casein in cells associated with domes suggest that the BuMECs can differentiate to express lactation specific proteins such as casein. Our findings are consistent with the earlier report in caprine [19] MECs. Lee et al. [53] reported that immunostaining for p-casein in mouse MECs revealed stronger fluorescence in the cells surrounding the dome. They suggested that casein synthesis on plastic is related to topology of the monolayer and low level of casein production in cells away from the dome was attributed to heterogeneity of casein producing cells on the plastic substratum [53] . Parry et al. [54] reported a strong positive anti-p-casein antibody reaction in areas of mammary cell monolayer which became detached from glass coverslips. The presence of casein detected at mRNA and protein level in BuMECs suggests that they undergo differentiation and express lactation specific proteins in the absence of an exogenous matrix. The characteristics of BuMECs described so far suggest that they express normal cellular functions specific to mammary epithelial cells. Furthermore these BuMECs maintained normal diploid chromosome number both at early and late passage indicating that the cells maintained non-transformed lineage.
In conclusion, in the present investigation, we have reported the development of a spontaneously immortalized BuMEC line which has been maintained long-term in culture with growth and functional properties unique to MECs. This cell line can be used as a model system for functional study involving mammary cell function, genomics, transcriptomics and proteomics for under standing mammary gland biology in general and mammary biology of buffalo in particular. This can also serve as a therapeutic model for application in breast cancer research. 
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